We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Neurology

Electrical Vestibular Stimulation: A Promising Adjunct Therapy for Adult Insomnia in Hong Kong

MedXY Editorial Team•Oct 8, 2025•Neurology
Insomnianeuromodulation

Introduction

Insomnia is a common sleep disorder characterized by difficulty initiating or maintaining sleep, or non-restorative sleep, resulting in impaired daytime functioning. Globally, insomnia affects approximately 10-30% of adults, posing substantial public health challenges due to its impact on quality of life, cognitive function, and overall health. Conventional treatments include pharmacotherapy and cognitive behavioral therapy (CBT), yet many patients seek complementary and non-pharmacological interventions due to concerns about medication side effects and accessibility to CBT.

Electrical vestibular stimulation (VeNS) is an emerging neuromodulation technique that delivers low-level electrical currents to the vestibular system, potentially influencing neural circuits involved in sleep regulation. While preliminary studies in Western populations suggest VeNS may improve sleep quality, robust clinical evidence remains limited, particularly within Asian cohorts.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Targeting the Medial Prefrontal Cortex with Low-Frequency rTMS: A Novel Approach for Visceral Pain Relief in IBS-DLow-frequency repetitive transcranial magnetic stimulation targeting the medial prefrontal cortex reduces visceral pain and improves bowel symptoms in IBS-D by normalizing central neural hyperexcitability.Aug 17, 2026Comorbid Insomnia Amplifies Blood Pressure Reduction with CPAP Therapy in Obstructive Sleep Apnea PatientsIn patients with OSA and elevated blood pressure, comorbid insomnia is linked to a significantly greater blood pressure reduction following short-term CPAP therapy, highlighting the clinical importance of addressing both sleep disorders.Aug 4, 2026Sham-Controlled Trial Finds Translumbosacral Neuromodulation May Reduce Fecal IncontinenceIn a sham-controlled trial, translumbosacral neuromodulation with 2400 or 3600 magnetic pulses reduced fecal incontinence episodes, improved severity scores and quality of life, and was well tolerated, with the higher dose showing the stronMay 13, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
High-Frequency TENS Shows Promise for Nociplastic Ocular Pain in Randomized Pilot Trial
This randomized pilot study demonstrates that high-frequency TENS significantly improves specific neuropathic ocular pain symptoms over three months, offering a non-invasive, non-pharmacological alternative for patients with refractory ocul
Mar 13, 2026
Synergistic Neuromodulation: Combined rTMS and tDCS Outperform Monotherapy in Patients with Anxious DepressionA double-blind RCT involving 240 patients reveals that combining rTMS and tDCS significantly improves remission rates and symptom reduction in Major Depressive Disorder with comorbid anxiety compared to single-modality or sham treatments, pFeb 23, 2026
ESTIVAL Trial: Auricular Vagus Nerve Stimulation for Erosive Hand Osteoarthritis Falls Short of Primary Endpoint but Shows Signals in Inflammatory SubgroupsThe ESTIVAL trial investigated transcutaneous auricular vagus nerve stimulation (taVNS) for erosive hand osteoarthritis. While the primary pain reduction endpoint was not met, the therapy proved safe and showed potential efficacy in patientFeb 19, 2026